{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:35:21Z","timestamp":1785825321267,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene,Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"PhRMA Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jval.2019.01.015","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T20:03:15Z","timestamp":1558036995000},"page":"762-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States"],"prefix":"10.1016","volume":"22","author":[{"given":"Jingxuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Davidoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Banegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedin","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Robin","family":"Yabroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jval.2019.01.015_bib1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jama.2016.11237","article-title":"The high cost of prescription drugs in the United States: origins and prospects for reform","volume":"316","author":"Kesselheim","year":"2016","journal-title":"JAMA"},{"issue":"30","key":"10.1016\/j.jval.2019.01.015_bib2","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","article-title":"Economic burden of cancer survivorship among adults in the United States","volume":"31","author":"Guy","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.jval.2019.01.015_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.30560","article-title":"Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States","volume":"123","author":"Zheng","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jval.2019.01.015_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/jnci\/djx164","article-title":"Trends in financial access to prescription drugs among cancer survivors","volume":"110","author":"Gonzales","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"20","key":"10.1016\/j.jval.2019.01.015_bib5","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/cncr.28262","article-title":"Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?","volume":"119","author":"Kent","year":"2013","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jval.2019.01.015_bib6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","article-title":"Patient adherence and medical treatment outcomes: a meta-analysis","volume":"40","author":"DiMatteo","year":"2002","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.jval.2019.01.015_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00019053-200725060-00004","article-title":"Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia","volume":"25","author":"Darkow","year":"2007","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.jval.2019.01.015_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaoncol.2018.0097","article-title":"Patterns in health care access and affordability among cancer survivors during implementation of the Affordable Care Act","volume":"4","author":"Nipp","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6S","key":"10.1016\/j.jval.2019.01.015_bib9","doi-asserted-by":"crossref","first-page":"60s","DOI":"10.1200\/JOP.2013.000971","article-title":"Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer","volume":"9","author":"Zullig","year":"2013","journal-title":"J\u00a0Oncol Pract"},{"issue":"165","key":"10.1016\/j.jval.2019.01.015_bib10","first-page":"1","article-title":"Design and estimation for the National Health Interview Survey, 2006-2015","author":"Parsons","year":"2014","journal-title":"Vital Health Stat 2"},{"issue":"6","key":"10.1016\/j.jval.2019.01.015_bib11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related medication nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"issue":"5","key":"10.1016\/j.jval.2019.01.015_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jval.2019.01.015_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.annemergmed.2013.04.013","article-title":"The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries","volume":"62","author":"Blanchard","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.jval.2019.01.015_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MLR.0b013e3181c12e53","article-title":"Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis","volume":"48","author":"Heisler","year":"2010","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.jval.2019.01.015_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bmjqs-2017-007453","article-title":"Hospital admissions associated with medication non-adherence: a systematic review of prospective observational studies","volume":"27","author":"Mongkhon","year":"2018","journal-title":"BMJ Qual Saf"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","article-title":"Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors","volume":"34","author":"Yabroff","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jval.2019.01.015_bib17","series-title":"Health Insurance Coverage in the United States: 2016","author":"Barnett","year":"2017"},{"issue":"10","key":"10.1016\/j.jval.2019.01.015_bib18","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2105\/AJPH.2016.303269","article-title":"Medication costs and adherence of treatment before and after the Affordable Care Act: 1999-2015","volume":"106","author":"Kennedy","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jval.2019.01.015_bib19","series-title":"Multiple imputation of family income and personal earnings in the National Health Interview Survey: methods and examples","year":"2017"},{"key":"10.1016\/j.jval.2019.01.015_bib20","article-title":"Disparities in insurance coverage, health services use, and access following implementation of the Affordable Care Act: a comparison of disabled and nondisabled working-age adults","volume":"54","author":"Kennedy","year":"2017","journal-title":"Inquiry"},{"issue":"suppl 11","key":"10.1016\/j.jval.2019.01.015_bib21","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.28066","article-title":"Health care policy and cancer survivorship","volume":"119","author":"Virgo","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PPO.0000000000000259","article-title":"The Affordable Care Act and cancer care delivery","volume":"23","author":"Brooks","year":"2017","journal-title":"Cancer J"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/PPO.0000000000000260","article-title":"Effects of Affordable Care Act marketplaces and Medicaid eligibility expansion on access to cancer care","volume":"23","author":"Graves","year":"2017","journal-title":"Cancer J"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PPO.0000000000000265","article-title":"The Affordable Care Act and cancer care for young adults","volume":"23","author":"Han","year":"2017","journal-title":"Cancer J"},{"key":"10.1016\/j.jval.2019.01.015_bib25","series-title":"Understanding Short-Term Limited Duration Health Insurance","author":"Pollitz","year":"2018"},{"issue":"19","key":"10.1016\/j.jval.2019.01.015_bib26","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.29512","article-title":"Are high drug prices for hematologic malignancies justified? A critical analysis","volume":"121","author":"Chhatwal","year":"2015","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jval.2019.01.015_bib27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1377\/hlthaff.2014.0001","article-title":"National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011","volume":"33","author":"Conti","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.1016\/j.jval.2019.01.015_bib28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/jamaoncol.2016.0648","article-title":"Drug pricing trends for orally administered anticancer medications reimbursed by commercial health plans, 2000-2014","volume":"2","author":"Dusetzina","year":"2016","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.jval.2019.01.015_bib29","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jamainternmed.2017.2788","article-title":"Possible insufficiency of generic price competition to contain prices for orally administered anticancer therapies","volume":"177","author":"Cole","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jval.2019.01.015_bib30","author":"Claxton"},{"issue":"4","key":"10.1016\/j.jval.2019.01.015_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1200\/JCO.2013.52.9123","article-title":"Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia","volume":"32","author":"Dusetzina","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.jval.2019.01.015_bib32","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2010.33.3179","article-title":"Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer","volume":"29","author":"Neugut","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jamainternmed.2016.8747","article-title":"Precision benefit design\u2014using \u201csmarter\u201d deductibles to better engage consumers and mitigate cost-related nonadherence","volume":"177","author":"Fendrick","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1377\/hlthaff.2016.1316","article-title":"Value-based insurance design benefit offsets reductions in medication adherence associated with switch to deductible plan","volume":"36","author":"Reed","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.1016\/j.jval.2019.01.015_bib35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1377\/hlthaff.2012.0902","article-title":"Value-based insurance design: quality improvement but no cost savings","volume":"32","author":"Lee","year":"2013","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.1016\/j.jval.2019.01.015_bib36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1377\/hlthaff.2017.1633","article-title":"Value-based insurance design improves medication adherence without an increase in total health care spending","volume":"37","author":"Agarwal","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JOP.2015.004408","article-title":"Cost-related health literacy: a key component of high-quality cancer care","volume":"11","author":"Zafar","year":"2015","journal-title":"J\u00a0Oncol Pract"},{"issue":"23","key":"10.1016\/j.jval.2019.01.015_bib38","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","article-title":"American Society of Clinical Oncology guidance statement: the cost of cancer care","volume":"27","author":"Meropol","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jval.2019.01.015_bib39","series-title":"Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis","author":"Levit","year":"2013"},{"issue":"3","key":"10.1016\/j.jval.2019.01.015_bib40","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1200\/JOP.2015.007401","article-title":"Physician experience and attitudes toward addressing the cost of cancer care","volume":"12","author":"Altomare","year":"2016","journal-title":"J\u00a0Oncol Pract"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519300798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519300798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:15:34Z","timestamp":1761095734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519300798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1098301519300798"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2019.01.015","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2019.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}